Stemline Therapeutics Inc (NASDAQ:STML)

14.47
Delayed Data
As of Mar 31
 -0.61 / -4.05%
Today’s Change
10.50
Today|||52-Week Range
21.28
-15.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-2.8M-6.3M-24.2M--
 
 
 
 
Depreciation0.00--76.7K--
 
 
Total Other Cash Flow108.3K611.0K5.3M--
 
 
 
 
Funds From Operations-2.5M-5.7M-18.8M--
 
 
 
 
Funds From/For Other Operating Expenses-601.4K-1.5M-2.7M--
 
 
 
 
Net Cash Flow - Operating Activities-1.9M-4.1M-16.1M--
 
 
 
 
 
InvestingIncrease In Investments0.000.00-40.2M--
 
 
Capital Expenditures0.000.00-460.0K--
 
 
Net Cash Flow Investing0.000.00-40.7M--
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings540.0K322.0K0.00--
 
 
 
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale0.000.0099.0M--
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.00----
Other Uses - Financing0.000.000.00----
Net Cash Flow - Financing540.0K322.0K99.0M--
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash-1.4M-3.8M42.2M0.00
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account